Skip to main content
Veterinary Medicines

Tendease 50,000 IU/100 g gel for horses

Authorised
  • Levomenthol
  • Hydroxyethyl salicylate
  • Heparin sodium

Product identification

Medicine name:
Tendease 50,000 IU/100 g gel for horses
Tendease 50.000 IE/100 g gel voor paarden
Active substance:
  • Levomenthol
  • Hydroxyethyl salicylate
  • Heparin sodium
Target species:
  • Horse
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Levomenthol
    0.50
    gram(s)
    /
    100.00
    gram(s)
  • Hydroxyethyl salicylate
    5.00
    gram(s)
    /
    100.00
    gram(s)
  • Heparin sodium
    50.00
    international unit(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Gel
Withdrawal period by route of administration:
  • Cutaneous use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM02AC99
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • (ID2): 1 unspecified outer container with 6 Bottle (PolyEthylene) with 300 gram(s) (1800 gram(s))
  • (ID1): 1 unspecified outer container with 1 Bottle (PolyEthylene) with 300 gram(s) (300 gram(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera Istrazivanja d.o.o.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 111340
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0148/001
Concerned member states:
  • Belgium
  • Netherlands

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/02/2022

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."